JP2013510169A5 - - Google Patents

Download PDF

Info

Publication number
JP2013510169A5
JP2013510169A5 JP2012538031A JP2012538031A JP2013510169A5 JP 2013510169 A5 JP2013510169 A5 JP 2013510169A5 JP 2012538031 A JP2012538031 A JP 2012538031A JP 2012538031 A JP2012538031 A JP 2012538031A JP 2013510169 A5 JP2013510169 A5 JP 2013510169A5
Authority
JP
Japan
Prior art keywords
amino acid
amount
domain
compound
fusion protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012538031A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013510169A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/055636 external-priority patent/WO2011057081A1/en
Publication of JP2013510169A publication Critical patent/JP2013510169A/ja
Publication of JP2013510169A5 publication Critical patent/JP2013510169A5/ja
Pending legal-status Critical Current

Links

JP2012538031A 2009-11-06 2010-11-05 呼吸器管の治療及び予防のための方法、化合物、及び組成物 Pending JP2013510169A (ja)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US25905509P 2009-11-06 2009-11-06
US25903309P 2009-11-06 2009-11-06
US61/259,055 2009-11-06
US61/259,033 2009-11-06
US32281310P 2010-04-09 2010-04-09
US61/322,813 2010-04-09
US33206310P 2010-05-06 2010-05-06
US61/332,063 2010-05-06
US38142010P 2010-09-09 2010-09-09
US61/381,420 2010-09-09
PCT/US2010/055636 WO2011057081A1 (en) 2009-11-06 2010-11-05 Methods, compounds and compositions for treatment and prophylaxis in the respiratory tract

Publications (2)

Publication Number Publication Date
JP2013510169A JP2013510169A (ja) 2013-03-21
JP2013510169A5 true JP2013510169A5 (enExample) 2013-12-26

Family

ID=43970356

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012538031A Pending JP2013510169A (ja) 2009-11-06 2010-11-05 呼吸器管の治療及び予防のための方法、化合物、及び組成物

Country Status (8)

Country Link
US (6) US8398971B2 (enExample)
EP (1) EP2496251A4 (enExample)
JP (1) JP2013510169A (enExample)
CN (1) CN102711807A (enExample)
AU (1) AU2010315024B2 (enExample)
CA (1) CA2780193A1 (enExample)
IL (1) IL219579B (enExample)
WO (1) WO2011057081A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8512710B2 (en) 2002-11-22 2013-08-20 Ansun Biopharma, Inc. Class of therapeutic protein based molecules
JP2013510169A (ja) * 2009-11-06 2013-03-21 ネクスバイオ，インク． 呼吸器管の治療及び予防のための方法、化合物、及び組成物
CA2864746A1 (en) 2012-02-17 2013-08-22 Ansun Biopharma, Inc. Methods, compounds and compositions for treatment of influenza and parainfluenza patients
US20140154308A1 (en) * 2012-06-28 2014-06-05 Ansun Biopharma, Inc. Microparticle Formulations for Delivery to the Upper and Central Respiratory Tract and Methods of Manufacture
JP2015527310A (ja) 2012-06-28 2015-09-17 アンサン バイオファーマ, インコーポレイテッドAnsun Biopharma, Inc. 下気道および中枢気道への送達用微粒子製剤ならびに製造方法
FR3022256B1 (fr) * 2014-06-17 2018-03-09 Adisseo France S.A.S. Nouvelles souches d’arthrobacter gandavensis
ES2947312T3 (es) 2016-07-01 2023-08-04 Univ Leland Stanford Junior Conjugados para la edición dirigida de la superficie celular
CN108926707B (zh) * 2017-05-26 2021-12-03 中国医学科学院病原生物学研究所 Pf4的抗rsv应用
JP7462560B2 (ja) 2018-01-03 2024-04-05 パレオン ファーマシューティカルズ インコーポレイテッド 組換えヒトシアリダーゼ、シアリダーゼ融合タンパク質およびそれらの使用方法
CN109288114A (zh) * 2018-10-08 2019-02-01 厦门艾赛生物科技有限公司 一种唾液酸及其衍生物的应用和唾液酸电子烟液
AU2020301037A1 (en) * 2019-07-03 2022-02-03 Palleon Pharmaceuticals Inc. Recombinant human sialidases, sialidase fusion proteins, and methods of using the same
JP2023520703A (ja) * 2020-04-01 2023-05-18 ライフサイエンス エイエス コロナウイルス感染症の防止および治療における使用のためのシアル酸組成物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7019A (en) * 1850-01-15 Improvement in obstetrical supporters
US8501911B2 (en) * 1999-02-24 2013-08-06 Biomarck Pharmaceuticals, Ltd Methods of reducing inflammation and mucus hypersecretion
US7807174B2 (en) * 2002-11-22 2010-10-05 Nexbio, Inc. Class of therapeutic protein based molecules
EP1981483A1 (en) * 2006-01-24 2008-10-22 Nexbio, Inc. Technology for preparation of macromolecular microspheres
CN103784408A (zh) * 2007-07-24 2014-05-14 安迅生物制药公司 用于制备微粒的技术
US20090196930A1 (en) * 2007-12-27 2009-08-06 Aires Pharmaceuticals, Inc. Aerosolized nitrite and nitric oxide -donating compounds and uses thereof
JP2013510169A (ja) * 2009-11-06 2013-03-21 ネクスバイオ，インク． 呼吸器管の治療及び予防のための方法、化合物、及び組成物

Similar Documents

Publication Publication Date Title
EA201270221A1 (ru) Лечение болезни крона с применением лаквинимода
JP2015517489A5 (enExample)
JP2008530245A5 (enExample)
JP2011528896A5 (enExample)
MY157564A (en) Combination pharmaceutical composition and methods of treating functional diseases or conditions of gastrointestinal tract
WO2010062688A3 (en) Dosage form for insertion into the mouth
WO2008151235A3 (en) Compositions for delivering medicaments into the lungs, uses thereof
JP2008529558A5 (enExample)
JP2010202664A5 (enExample)
WO2010139808A3 (en) Monovalent, bivalent and trivalent anti human respiratory syncytial virus (hrsv) nanobody constructs for the prevention and/or treatment of respiratory tract infections
JP2016509011A5 (enExample)
JP2010529999A5 (enExample)
JP2014503593A5 (enExample)
JP2011511805A5 (enExample)
WO2007092563A3 (en) Gene therapy for niemann-pick disease type a
JP2009517473A5 (enExample)
JP2011528897A5 (enExample)
JP2013526392A5 (enExample)
JP2011225596A5 (enExample)
WO2008064299A3 (en) Methods of reducing porcine circovirus-associated disease outbreaks
MY153408A (en) Novel methods
JP2014513722A5 (enExample)
WO2010068754A3 (en) Methods and compositions for delivery of medicaments to the lungs
JP2010534684A5 (enExample)
MD4369B1 (ro) Utilizarea glicopirolatului pentru tratarea tahicardiei, doză unică, dispozitiv de administrare, metodă de tratament şi profilaxie a tahicardiei